Retatrutide's own published trials, the Phase 2 study in the New England Journal of Medicine and the Phase 3 TRIUMPH-1 results released in May 2026, did not list hair loss or alopecia among the reported side effects
With the right approach, L-Carnitine can help you achieve your fitness goals and enhance your overall well-being.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, openlabel, randomised, phase 3a trial
Rev Endocr Metab Disord 15(3):181187 Shan Y, Tan S, Lin Y, Liao S, Zhang B, Chen X et al (2019) The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke
Batch-coded vial for product identification and traceability